The price-to-earning (P/E) ratios of a few pharmaceutical stocks are currently higher than the industry average of 12.21, indicating expectations of good results from these companies.
For instance, Astra Zeneca
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The price-to-earning (P/E) ratios of a few pharmaceutical stocks are currently higher than the industry average of 12.21, indicating expectations of good results from these companies.
For instance, Astra Zeneca
First Published: Oct 30 2002 | 12:00 AM IST